Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

7 publications

Funding

1 grant
Completed grants (1)
  • Sub-PI
    International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) 018 STRIVE Platform Trial
    National Institute of Allergy and Infectious Diseases · 2022–2025 · via Institute for Clinical Research
    75N91020F00039/ 18X107CF6

Clinical research

8 studies

Active

1 study
  • PI
    A Prospective Randomized Basket Trial Evaluating the Clinical Utility of Plasma-based Microbial Cell-free Metagenomic Sequencing for Diagnosis and Management of Suspected Infections in Adult Immunocompromised Outpatients
    NA · Karius, Inc · OPEN TO ACCRUAL (as of 2026)
    Infection; Infections, Bacterial; Infections, Fungal; Infection Viral; Parasitic Disease
    NCT07110636
Completed & closed trials (7)
  • PI
    Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor
    PHASE3 · University of Minnesota · IRB STUDY CLOSURE (as of 2025)
    COVID-19
    NCT05605093
  • PI
    Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
    PHASE4 · University of Minnesota · IRB STUDY CLOSURE (as of 2025)
    COVID-19
    NCT05822583
  • PI
    Treatment of a single patient infected with Cavitary Mycobacterium avium infection using Clofazimine (Lamprene)
    Novartis Pharmaceuticals Corporation · IRB STUDY CLOSURE (as of 2023)
  • PI
    A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Coadministration of SCY-078 With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
    PHASE2 · Scynexis, Inc. · IRB STUDY CLOSURE (as of 2022)
    Invasive Pulmonary Aspergillosis
    NCT03672292
  • PI
    Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens
    Karius, Inc · IRB STUDY CLOSURE (as of 2022)
    Pneumonia, Bacterial; Pneumonia, Viral; Pneumonia Fungal; Pneumonia Cavitary; Immunocompromised Host
    NCT04047719
  • PI
    Compassionate Use of Maribavir
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2021)
  • PI
    A Randomized, Controlled, Open-Label, Multiple Ascending Dose Study of Intravenous Brincidofovir in Adult Allogeneic Hematopoietic Cell Transplant Recipients With Adenovirus Viremia
    PHASE2 · Chimerix, Inc. · IRB STUDY CLOSURE (as of 2020)
    Adenovirus
    NCT03532035